Digital twin could boost liver cancer therapy accuracy
NCT ID NCT07315633
First seen Jan 04, 2026 · Last updated May 19, 2026 · Updated 25 times
Summary
This study aims to improve a liver cancer treatment called TARE, which delivers radiation directly to tumors through blood vessels. Researchers will create computer models of each patient's liver blood flow to predict where the radiation goes. The goal is to help doctors plan treatments that better target tumors and spare healthy tissue. The study involves 80 adults with liver cancer who are receiving or eligible for TARE.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LIVER CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University Hospital Ghent
RECRUITINGGhent, 9000, Belgium
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.